- Under the terms of the proposed settlement, the Company will pay $225M to the United States and the State of Illinois, plus approximately $9M in legal fees, and will not admit any wrongdoing. Additionally, in connection with the settlement, the Company will enter into a Corporate Integrity Agreement with the Office of the Inspector General of the U.S. Department of Health and Human Services.
- The Company will report a one-time charge for the settlement of approximately $199M net of the estimated tax benefit, in the second quarter ended June 30, 2008. The Company will pay the settlement from restricted funds previously established to cover costs related to the judgment. Following the payment, which is expected to occur during the third quarter of 2008, the Company's unrestricted cash balance will increase by approximately $117M due to the release of excess restricted funds.

Other headlines for [AGP]

• Yesterday 08:15am
  Merrill cutting price targets in numerous managed care names- HUM price target cut to $40 from $48 - MGLN price target cut to $44 from $47 - WLP price target remains $48 - CI price target remains more...
  
• AGP 11/20/2008 08:35am
  AMERIGROUP Corp To Acquire New Jersey Medicaid Business, Sell Medicaid Business in South Carolina- Plans to purchase certain assets from Centene Corporation, principally the right to provide managed care services to more...
  
• AGP 11/5/2008 12:08pm
  AMERIGROUP Corp Merrill Lynch Cuts AGP to Sell from Buy, price target: $24 (timing uncertain)
  
• AGP 10/27/2008 07:59am
  AMERIGROUP Corp FTN Midwest Research Securities Corp Raised AGP to Buy from Neutral
  
• AGP 10/24/2008 02:49pm
  AMERIGROUP Corp BofA Raised AGP to Buy from Neutral (timing uncertain)
  

Healthcare sector headlines

• GNBT Today 09:30am
  Generex Biotechnology Announces Positive Results of Metformin Chewing Gum Trial- Results of this fully compliant ICH-GCP conducted study indicate that the MetControl Metformin chewing gum and traditional Metformin tablets more...
  
• Today 09:30am
  Fed sets overnight reverse repos, accepts $25B
  
• 4568.JP Today 09:28am
  Daiichi Sankyo Co Three Studies of Oral Factor Xa Inhibitor DU-176b Accepted for the 50th Annual Meeting of the American Society of Hematology- Results from three studies of its investigational molecule, DU-176b, will more...
  
• GENZ Today 09:22am
  Genzyme Corp European Patent on cross-linked Gel Slurries has been revoked by EPO board of appeal- Announces that the opposition they filed against European Patent EP 0466300 B1 to Genzyme Corporation has been more...
  
• NABI Today 09:15am
  Nabi Biopharmaceuticals Increases patent portfolio with receipt of two patents for components of PentaStaph- European Patent Office issued Patent EP No. 0 925 073 that provides composition-of-matter protection in the EU more...